APA
Vogiatzi F., Winterberg D., Lenk L., Buchmann S., Cario G., Schrappe M., Peipp M., Richter-Pechanska P., Kulozik A. E., Lentes J., Bergmann A. K., Valerius T., Frielitz F., Kellner C. & Schewe D. M. (20200127). Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia. : Blood.
Chicago
Vogiatzi Fotini, Winterberg Dorothee, Lenk Lennart, Buchmann Swantje, Cario Gunnar, Schrappe Martin, Peipp Matthias, Richter-Pechanska Paulina, Kulozik Andreas E, Lentes Jana, Bergmann Anke K, Valerius Thomas, Frielitz Fabian-Simon, Kellner Christian and Schewe Denis M. 20200127. Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia. : Blood.
Harvard
Vogiatzi F., Winterberg D., Lenk L., Buchmann S., Cario G., Schrappe M., Peipp M., Richter-Pechanska P., Kulozik A. E., Lentes J., Bergmann A. K., Valerius T., Frielitz F., Kellner C. and Schewe D. M. (20200127). Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia. : Blood.
MLA
Vogiatzi Fotini, Winterberg Dorothee, Lenk Lennart, Buchmann Swantje, Cario Gunnar, Schrappe Martin, Peipp Matthias, Richter-Pechanska Paulina, Kulozik Andreas E, Lentes Jana, Bergmann Anke K, Valerius Thomas, Frielitz Fabian-Simon, Kellner Christian and Schewe Denis M. Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia. : Blood. 20200127.